Posts tagged “Biotech & Life Science”

Updated March 16, 2007

Premium Lock Wall Street Pummels Trimeris Shares 29% in Wake of Changes

 UPDATE: Biopharmaceutical firm’s stock plunges to $7.12 in very heavy trading. Some analysts also downgrade Trimeris after company announces departure of CEO, CFO and end to one partnership with drug giant Roche.

Updated March 16, 2007

Premium Lock AIDS Pioneer Dani Bolognesi Retires in Management Shakeup at Trimeris

 Researcher who helped develop HIV drug Fuzeon is out as CEO as of Friday. CFO also will retire as a ‘turn-around’ executive is brought in. Meanwhile, Trimeris does report first profit, also regains drug candidate from partner Roche.

Updated March 15, 2007

Premium Lock Startup CeNeRx Reports Positive Results for Lead Product

cenerx Phase I trial shows no side effects on patients for drug candidate that targets depression, anxiety.

Updated March 13, 2007

Premium Lock FDA Grants Approval for New Breast Cancer Drug from GSK

gsk Tykerb used in combination with chemotherapy is a ‘breakthrough’ treatment, GSK says.

March 13, 2007

Premium Lock Biopharma Firm GenPhar Picks Charleston Area for $33M Vaccine Plant

GenPhar Company plans to hire 120 people for what would be first good manufacturing practice standard facility in South Carolina.

Updated March 12, 2007

Premium Lock SEBIO Picks Atlanta Patent Agent as New Executive Director

SEBIO UPDATE: Anne Wein, the first person to hold SEBIO post, steps down after two years. Stephanie Adams, her replacement, worked with King & Spalding law firm.

Tags: SEBIO, Emory
Updated March 9, 2007

Premium Lock Murdock Makes First Major Biotech Investment - $33M in Vaccine Firm

David Murdock UPDATE: Billionaire who is building N.C. Research Campus in Kannapolis also says firm would build manufacturing facility. His son Justin runs the venture.

March 9, 2007

Premium Lock Cystic Fibrosis Drug Developed by Chapel Hill Firm Shows Promise

drugs Lantibio has licensed compounded to European firm, which is conducting Phase II trials.

Updated March 7, 2007

Premium Lock ‘Safer Aspirin’ News Triggers Surge in Pozen Stock

pozen Chapel Hill pharmaceutical firm says proposed aspirin combination shows promise in tests. Stock climbs 10%.

March 2, 2007

Premium Lock etrials Lands Contract with ‘Top 10’ Pharma Firm for Clinical Trial

etrials Morrisville company will provide ‘eDiary’ services for nerve pain related to diabetes.

Updated March 1, 2007

Premium Lock LabCorp Loses Major Contract; Stock Takes Hit

LabCorp Analyst firm cuts LabCorp rating; Burlington-based firm says earnings will drop up to 12 cents per share.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith